MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1081.42%
Quick Ratio
1081.42%
Cash Ratio
230.02%
Debt to Asset Ratio
7.75%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, non-curre...
    • Marketable securities (note 4)
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Contract assets
-
-
0
0
Cash and cash equivalents
144,090
357,011
112,949
335,816
Marketable securities (note 4)
506,839
491,265
392,733
329,629
Accounts receivable
-
-
-
40,000
Prepaid expenses and other current assets
26,503
22,938
22,616
22,882
Total current assets
677,432
871,214
528,298
728,327
Marketable securities, non-current (note 4)
894,724
771,158
473,055
297,629
Property and equipment, net (note 6)
41,617
43,175
45,128
48,572
Right-of-use assets, operating leases
41,736
42,351
42,947
46,045
Other non-current assets
7,697
9,114
6,828
4,675
Restricted cash
5,810
5,800
5,788
5,820
Total assets
1,669,016
1,742,812
1,102,044
1,131,068
Accounts payable
12,839
4,015
5,506
5,781
Accrued expenses (note 8)
35,095
42,274
28,639
27,976
Deferred revenue
0
22,925
23,279
40,000
Operating lease liabilities
12,032
11,941
11,853
11,766
Finance lease liabilities
1,701
1,815
1,890
1,900
Other current liabilities
976
242
408
117
Total current liabilities
62,643
83,212
71,575
87,540
Deferred revenue, net of current portion
0
11,440
13,957
-
Operating lease liabilities, net of current portion
65,585
67,034
68,450
69,835
Finance lease liabilities, net of current portion
1,151
1,462
1,804
2,213
Total liabilities
129,379
163,148
155,786
159,588
Common stock, 0.0001 par value 150,000,000 shares authorized at march 31, 2026 and december 31, 2025, 82,182,101 and 81,323,532 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
8
8
7
7
Additional paid-in capital
2,679,018
2,643,817
1,923,730
1,867,999
Accumulated deficit
-1,135,195
-1,065,961
-978,980
-896,805
Accumulated other comprehensive loss
-4,194
1,800
1,501
279
Total stockholders equity
1,539,637
1,579,664
946,258
971,480
Total liabilities and stockholders equity
1,669,016
1,742,812
1,102,044
1,131,068
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities(note 4)$506,839K Cash and cashequivalents$144,090K Prepaid expenses andother current assets$26,503K Marketable securities,non-current (note 4)$894,724K Total current assets$677,432K Right-of-use assets,operating leases$41,736K Property and equipment,net (note 6)$41,617K Other non-currentassets$7,697K Restricted cash$5,810K Total assets$1,669,016K Total liabilities andstockholders equity$1,669,016K Total stockholdersequity$1,539,637K Total liabilities$129,379K Accumulated deficit-$1,135,195K Accumulated othercomprehensive loss-$4,194K Additional paid-in capital$2,679,018K Operating leaseliabilities, net of current...$65,585K Total currentliabilities$62,643K Finance leaseliabilities, net of current...$1,151K Common stock, 0.0001par value...$8K Accrued expenses (note8)$35,095K Accounts payable$12,839K Operating leaseliabilities$12,032K Finance leaseliabilities$1,701K Other currentliabilities$976K

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. (KYMR)